The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.30BCNY
793.89M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
440.23MCNY
65.99M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-21.74%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Beta
1.20x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-6.72%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
5.30BCNY
793.89M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
4.84BCNY
725.94M · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
639.00x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Sales (TTM)
12.03x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Book (MRQ)
3.46x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to Revenue
11.00x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Margin
38.44%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 29.35%.Updated Oct 21, 2026
Profit Margin
-21.74%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Margin
0.54%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Assets (TTM)
-1.98%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Equity (TTM)
-6.05%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
440.23MCNY
65.99M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
1.59CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-29.50%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Profit (TTM)
129.20MCNY
19.37M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
56.42MCNY
8.46M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-95.72MCNY
-14.35M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-29.52%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
204.77MCNY
30.69M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
167.98MCNY
25.18M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.25%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
55.01%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Minority Interest (Equity)
12.84MCNYFY2025 · Dec 31, 2025
Revenue
531.04MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
371.20MCNYFY2025 · Dec 31, 2025
Gross Profit
159.84MCNYFY2025 · Dec 31, 2025
Operating Income
-9.66MCNY
-1.45M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-125.00MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.77MCNYFY2025 · Dec 31, 2025
Net Income
-117.23MCNYFY2025 · Dec 31, 2025
EBIT
-117.37MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
56.42MCNYFY2025 · Dec 31, 2025
Research & Development
30.78MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
66.60MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
8.44MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.40MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
7.63MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4248CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4248CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
276.32MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
276.32MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-117.23MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-148.89KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
72.09MCNYFY2025 · Dec 31, 2025
Free Cash Flow
51.79MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
569.10MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-117.23MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.92MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
136.60MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
44.80MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-20.29MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-390.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
391.71MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-18.59MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
92.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-233.27MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.97MCNYFY2025 · Dec 31, 2025
Other Financing Charges
3.53MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-144.70MCNYFY2025 · Dec 31, 2025
Shares Outstanding
276.29MSharesUpdated Oct 21, 2026
Float Shares
177.69MSharesUpdated Oct 21, 2026
% Held by Insiders
40.34%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
1.70%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
586.82MCNY
87.96M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
2.12CNYUpdated Oct 21, 2026
Total Debt (MRQ)
81.76MCNY
12.25M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0517x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Current Ratio (MRQ)
2.80x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
5.54CNYUpdated Oct 21, 2026
Total Assets
2.18BCNY
327.23M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.47BCNYFY2025 · Dec 31, 2025
Total Liabilities
649.03MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
712.81MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
94.96MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
554.07MCNYFY2025 · Dec 31, 2025
Cash
539.36MCNYFY2025 · Dec 31, 2025
Cash Equivalents
85.02MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
624.39MCNYFY2025 · Dec 31, 2025
Accounts Receivable
505.85MCNYFY2025 · Dec 31, 2025
Inventory
266.67MCNYFY2025 · Dec 31, 2025
Accounts Payable
190.52MCNYFY2025 · Dec 31, 2025
Short-term Debt
116.83MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.92MCNYFY2025 · Dec 31, 2025
Long-term Debt
30.91MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
276.29MCNYFY2025 · Dec 31, 2025
Retained Earnings
283.64MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.53BCNY
229.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
13.65CNYUpdated Oct 21, 2026
52-Week High
26.88CNYUpdated Oct 21, 2026
52-Week Change
-6.72%
vs all stocks
Updated Oct 21, 2026
Beta
1.20x
vs all stocks
Updated Oct 21, 2026
50-Day MA
19.25CNYUpdated Oct 21, 2026
200-Day MA
20.20CNYUpdated Oct 21, 2026
Avg 10-Day Volume
6.84MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
7.62MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.3500CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.